Dr. Vimal D. Patel, MD

Dr. Patel practices at Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health.

Dr. Patel's NPI, 1932360617, was assigned on June 24, 2008. Dr. Patel graduated from Rutgers Robert Wood Johnson Medical School in 2005. Dr. Patel holds New Jersey license 25MA08416200.

Dr. Patel's primary practice is Robert Wood Johnson University Hospital, at One Robert Wood Johnson Place, New Brunswick, NJ 08901 in Middlesex County. The practice phone is (732) 828-3000. Dr. Patel also practices at Robert Wood Johnson University Hospital - New Brunswick, 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901.

Dr. Patel's primary practice is Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health. The medical group on file is Rutgers-RWJ Scleroderma Program. Dmand AI also links Dr. Patel to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Patel is board certified in hematology by the American Board of Internal Medicine. Dr. Patel is licensed in New Jersey.

Dmand AI lists purpura and thrombocytopenia among the conditions Dr. Patel treats.

CMS data shows 234 Medicare services from Dr. Patel across 5 procedure codes in 2024, for 72 Medicare patients. Medicare paid $25,821 for them.

CMS counts 72 Medicare patients who saw Dr. Patel in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 66, with 48% women.

In 2024, Dr. Patel wrote 238 Medicare Part D claims for 34 patients. 54% of them were for generic drugs. CMS names the drug for 141 of them, across 7 drugs with 11 or more claims each, at $637,557 in total drug cost. In 2023, CMS named 547 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Patel for performance year 2024, reported as part of a group. Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Patel as offering telehealth.

Dmand AI links 5 papers to Dr. Patel, published from 2012 to 2022. The most frequent topics are Graft vs Host Disease, Hematopoietic Stem Cell Transplantation and Allografts. Dr. Patel's most frequent co-authors are Dale G. Schaar, Roger K. Strair, MD and Dennis L. Cooper, MD.

CMS Open Payments shows 6 general payments to Dr. Patel from 6 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. CSL Behring paid the most, $119.

Dr. Patel graduated from Rutgers Robert Wood Johnson Medical School in 2005.

Dr. Patel is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, Horizon Blue Cross Blue Shield of New Jersey and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.